Mood Disorders: Clinical Trials

24 trials for Mood Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 unknown. 24 Phase 1, 11 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 124Unknown 24
Phase 211Unknown 11

Follow Mood Disorders: new trials by email Literature Review of Mood Disorders trials Research Report on Mood Disorders

Trials (filtered) newest first · largest first

All 24 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-Label Dose-Ranging Study of Oral SM-001 in Healthy Adults
SM-001 - Major Depression, Post Traumatic Stress Disorder
Phase 1UnknownAdvanced Integrative Medical Science Institute122023-10-012023-07-07
Altering Default Mode Network Activity With Transcranial Focused Ultrasound to Reduce Depressive Symptoms
Non-Invasive Transcranial Focused Ultrasound - Depressive Disorder, Major, Depression
Phase 1 / Phase 2UnknownUniversity of Arizona202023-04-272024-03-20
Influence of Oxycodone on Individuals Taking an SSRI
Oxycodone Hydrochloride, Placebo - Opioid Induced Respiratory Depression, Depressive Disorder
Phase 1UnknownLeiden University Medical Center552023-03-152023-02-15
The Effect of Ketamine on Aesthetics and Role for Antidepressant Effects
Ketamine, Placebo - Major Depressive Disorder
Phase 1UnknownMedical University of Vienna602022-06-012024-04-15
Brain Insulin Resistance in Mood Disorders
Humulin R, Diluent - Major Depressive Disorder, Bipolar Disorder
Phase 1 / Phase 2UnknownUniversity Health Network, Toronto1502021-10-062023-12-15
IMPase in Treatment-resistant Depression
Ebselen, Placebo - Depressive Disorder, Treatment-Resistant
Phase 1UnknownUniversity of Oxford502021-04-222023-07-06
Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2
PurWet, FurFat, PurApo - Sequelae of; Infection, Post Infection Glomerulonephritis
Phase 1 / Phase 2UnknownAll Natural Medicine Clinic, LLC20002021-03-012021-05-26
Imaging Neural Correlates of Ketamine Using PET/MR
Ketamine Hydrochloride, Esketamine, Placebo - Major Depressive Disorder
Phase 1UnknownMedical University of Vienna652020-10-052024-03-04
Clinical Study on the Safety and Effectiveness of Vagus Nerve Stimulation in the Treatment of Refractory Depression
vagus nerve stimulation - Refractory Depression
Phase 1 / Phase 2UnknownXijing Hospital102019-11-012019-11-06
Bright Light Therapy in the Treatment of Non-seasonal Bipolar Depression
Light - Bipolar Depression
Phase 1 / Phase 2UnknownAssistance Publique - Hôpitaux de Paris452019-09-302020-02-10
Deep Brain Stimulation for Treatment Resistant Depression
Active stimulation of the medial forebrain bundle or subcallosal cingulate, Sham stimulation - Treatment Resistant Depression
Phase 1 / Phase 2UnknownSunnybrook Health Sciences Centre102019-06-152023-12-05
Ketamine for Major Depressive Disorder
SHX-001 Active low dose, Placebo, SHX-001 Active High dose - Major Depressive Disorder
Phase 1UnknownShenox Pharmaceuticals, LLC142018-12-282019-04-25
Scopolamine in Healthy Volunteers
Scopolamine - Major Depressive Disorder (MDD)
Phase 1UnknownRepurposed Therapeutics, Inc.1302018-08-012020-02-17
Cognitive-Behavioral Rehabilitation for Bipolar Disorder
Cognitive Behavioral Rehabilitation, Treatment as Usual - Bipolar Disorder
Phase 1 / Phase 2UnknownUniversity of Sao Paulo602016-03-012022-05-26
tVNS for Depression
Transcutaneous Vagus Nerve Stimulation - Depressive Disorder
Phase 1 / Phase 2UnknownSanta Casa Medical School402015-11-012015-09-29
TNS for Treating Major Depressive Disorder in the Elderly
Transcutaneous Trigeminal Nerve Stimulation - Major Depressive Disorder, Elderly
Phase 1 / Phase 2UnknownSanta Casa Medical School102015-10-012015-09-29
Low Field Magnetic Stimulation: Open Label Study.
Low Field Magnetic Stimulation - Mood Disorders, Anxiety
Phase 1 / Phase 2UnknownMclean Hospital402015-09-012016-04-13
Retrain Your Brain in Children/Adolescents With Bipolar Disorder: A Pilot Study
COGFLEX-skill building levels, COGFLEX-control condition - Bipolar Disorder, Pediatric Bipolar Disorder
Phase 1UnknownBradley Hospital402013-08-012018-01-18
Effects of Repeated Attachment Security Priming on Depressed Mood: a Clinical Study
Attachment security priming - Unipolar Depression
Phase 1UnknownUniversity of Southampton1002012-11-012012-09-26
Open Study Assessing the Feasibility of Minocycline in Patients With Unipolar Depression
Minocycline - Unipolar Depression
Phase 1UnknownShalvata Mental Health Center302012-06-012012-07-04

Showing 20 of 24. Sign in to see all of them.

Narrower conditions

Depressive Disorder, Major (11)  ·  Bipolar Disorder (6)  ·  Depression (5)  ·  Depressive Disorder (4)  ·  Depressive Disorder, Treatment-Resistant (4)  ·  Anxiety Disorders (3)  ·  Stress Disorders, Post-Traumatic (2)  ·  Ageusia (1)  ·  Anhedonia (1)  ·  Anosmia (1)  ·  Arthritis, Reactive (1)  ·  COVID-19 stress syndrome (1)  ·  Consciousness Disorders (1)  ·  Dementia (1)

Broader conditions

Mental Disorders (23)  ·  Depressive Disorder (14)  ·  Bipolar and Related Disorders (6)  ·  Behavior (5)  ·  Behavioral Symptoms (5)  ·  Nervous System Diseases (5)  ·  Neurologic Manifestations (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Neurobehavioral Manifestations (3)  ·  Neurocognitive Disorders (2)  ·  Stress Disorders, Traumatic (2)  ·  Trauma and Stressor Related Disorders (2)  ·  Arthritis (1)

Interventions

Ketamine (3)  ·  Cognitive Training (1)  ·  Esketamine (1)  ·  Insulin (1)  ·  Minocycline (1)  ·  Oxycodone (1)  ·  Oxytocin (1)  ·  Saline Solution (1)  ·  Scopolamine (1)  ·  Therapeutics (1)  ·  Ultraviolet Therapy (1)  ·  Vagus Nerve Stimulation (1)  ·  ebselen (1)  ·  tibolone (1)

Sponsors

Medical University of Vienna (2)  ·  Santa Casa Medical School (2)  ·  Advanced Integrative Medical Science Institute (1)  ·  All Natural Medicine Clinic, LLC (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bradley Hospital (1)  ·  GAAD Medical Research Institute Inc. (1)  ·  Leiden University Medical Center (1)  ·  Mclean Hospital (1)  ·  Mount Sinai Hospital, Canada (1)  ·  Repurposed Therapeutics, Inc. (1)  ·  Shalvata Mental Health Center (1)  ·  Shenox Pharmaceuticals, LLC (1)  ·  Shi Jinyun (1)  ·  Sunnybrook Health Sciences Centre (1)

Countries

United States (7)  ·  Canada (4)  ·  Austria (2)  ·  China (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Brazil (1)  ·  France (1)  ·  Israel (1)

Top investigators

Albert Dahan, MD PhD (1)  ·  Beny Lafer, Professor (1)  ·  Charlotte Keating, PhD (1)  ·  Daniel Dickstein, M.D. (1)  ·  David R Helton (1)  ·  Jessica N Schachtner, BA (1)  ·  Jianjun Yang, Dr (1)  ·  Joel Sadavoy, M.D. (1)  ·  John JB Allen, PhD (1)  ·  Ken Nedd, M.D. (1)  ·  Kwasi Donyina, Ph.D. (1)  ·  Leanna J Standish, ND PhD (1)  ·  Mason Freeman, MD (1)  ·  Michael L Rohan, Ph.D. (1)  ·  Philip J Cowen, MBBS, MD (1)

Results publications

PMID 25150403, PMID 23773978, PMID 25054988, PMID 26358492, PMID 28351410, PMID 30466205, PMID 40256163, PMID 40608475, PMID 41641082, PMID 41693798

NIH funding

R21MH096850 (1), R33MH096850 (1)